New Reports on Cancer/Oncology Market July Update by MarketsandMarkets

DALLAS, July 8, 2010 /PRNewswire/ -- MarketsandMarkets published new market research reports in Cancer/Oncology industry reports

Global Oncology Pharmaceuticals & Therapeutics Market ( http://www.marketsandmarkets.com/Market-Reports/oncology-pharmaceuticals-ther apeutics-arket-152.html)

(Due to the length of these URLs, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles.

August 2010 $ 4650

    Global Colon Cancer Market (2010-2015) (
http://www.marketsandmarkets.com/Market-Reports/colon-cancer-market-220.html)

2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate.

August 2010 $ 4650

Global Chronic Lymphocytic Leukemia Market ( http://www.marketsandmarkets.com/Market-Reports/chronic-lymphocytic-leukemia- 223.html)

2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates.

August 2010 $ 4650

Global Multiple Myeloma Drugs Market ( http://www.marketsandmarkets.com/Market-Reports/multiple-myeloma-drugs-221.ht ml)

2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates.

August 2010 $ 4650

Global Breast Cancer Drugs Market ( http://www.marketsandmarkets.com/Market-Reports/breast-cancer-market-201.html )

There are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market.

August 2010 $ 4650

Global Non Small Cell Lung Cancer/Oncology Drugs Market ( http://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html)

2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate.

August 2010 $ 4650

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: [email protected]
    http://www.marketsandmarkets.com


SOURCE MarketsandMarkets

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.